Table 2.
N | % | |
---|---|---|
Cryptogenic | 171 | 52.5 |
Pneumonia | 53 | 16.3 |
Emphysema | 26 | 8.0 |
Bronchiectasis | 19 | 5.8 |
Lung cancer | 13 | 4.0 |
Fibrosis | 8 | 2.5 |
Other infections | 4 | 1.2 |
Pulmonary embolus | 3 | 0.9 |
Anticoagulant treatment | 3 | 0.9 |
Heart failure | 2 | 0.6 |
Pleuritis | 2 | 0.6 |
Mucosal dysplasiaa | 2 | 0.6 |
Allergic alveolitis | 1 | 0.3 |
Metastatic gastrointestinal cancer | 1 | 0.3 |
Calcifications | 1 | 0.3 |
Cicatricial infiltration | 1 | 0.3 |
Desquamative interstitial pneumonia | 1 | 0.3 |
Oesophageal infection | 1 | 0.3 |
Hamartoma | 1 | 0.3 |
Atelectasis | 1 | 0.3 |
Idiopathic pulmonary fibrosis | 1 | 0.3 |
Lymphoid interstitial pneumonia | 1 | 0.3 |
Osler syndrome | 1 | 0.3 |
Metastatic breast cancer | 1 | 0.3 |
Tuberculosis | 1 | 0.3 |
Metastatic hepatic cancer | 1 | 0.3 |
Rib fracture | 1 | 0.3 |
Sarcoidosis | 1 | 0.3 |
Bronchitis | 1 | 0.3 |
Pneumothorax | 1 | 0.3 |
Vascular malformation | 1 | 0.3 |
Tuberculosis sequelae | 1 | 0.3 |
Total | 326 | 100.0 |
Patients with ongoing clinical follow-ups including bronchoscopy.